Newer beta blockers and the treatment of hypertension.

Article Details

Citation

Copy to clipboard

McAreavey D, Vermeulen R, Robertson JI

Newer beta blockers and the treatment of hypertension.

Cardiovasc Drugs Ther. 1991 Jun;5(3):577-87.

PubMed ID

1678961 [ View in PubMed

]

Abstract

Beta-adrenoceptor blocking agents are established as one of the principal classes of antihypertensive agents. Despite progressive refinements over the years, they still possess some unwanted effects, which limit their considerable value. In recent years a wide range of variations upon the beta-blocker theme has been developed. The full clinical advantages of the newer agents remain to be defined.

DrugBank Data that Cites this Article

Pharmaco-metabolomics

Drug	Drug Groups	Metabolite	Change	Description
Betaxolol	Approved Investigational	Triglycerides	decreased	Betaxolol decreases the level of Triglycerides in the blood
Betaxolol	Approved Investigational	LDL cholesterol	decreased	Betaxolol decreases the level of LDL cholesterol in the blood
Betaxolol	Approved Investigational	HDL cholesterol	increased	Betaxolol increases the level of HDL cholesterol in the blood
Bevantolol	Experimental	Triglycerides	increased	Bevantolol increases the level of Triglycerides in the blood
Bopindolol	Experimental	HDL cholesterol	increased	Bopindolol increases the level of HDL cholesterol in the blood
Bopindolol	Experimental	Triglycerides	increased	Bopindolol increases the level of Triglycerides in the blood
Bucindolol	Investigational	HDL cholesterol	increased	Bucindolol increases the level of HDL cholesterol in the blood
Celiprolol	Approved Investigational	Triglycerides	increased	Celiprolol increases the level of Triglycerides in the blood